Press Releases

All Releases

• Summary ToggleDexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time

  Jul 2, 2019

  SAN DIEGO --(BUSINESS WIRE)--Jul. 2, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2019 financial results after market close on Wednesday, July 31, 2019 . Management will hold a conference call to review the company's second quarter 2019 performance

  Read more
• Summary ToggleDexcom and Companion Medical Announce Collaboration to Integrate Dexcom CGM Data and InPen™ Insulin Data

  Jun 6, 2019

  SAN DIEGO --(BUSINESS WIRE)--Jun. 6, 2019-- DexCom, Inc. (NASDAQ:DXCM) and Companion Medical, Inc. today announced a collaboration to enable a direct exchange of CGM data from Dexcom with insulin data from InPen™ into both companies’ software applications.

  Read more
• Summary ToggleDexcom Announces Upcoming Conference Presentation

  May 22, 2019

  SAN DIEGO --(BUSINESS WIRE)--May 22, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli , Executive Vice President, Strategy and Corporate Development, will present an update on the company

  Read more
• Summary ToggleDexcom Reports First Quarter 2019 Financial Results

  May 1, 2019

  SAN DIEGO --(BUSINESS WIRE)--May 1, 2019-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2019 . First Quarter 2019 Highlights: Revenue grew 52% versus the same quarter of the prior year to $280.5 million U.S.

  Read more
• Summary ToggleDexcom Schedules First Quarter 2019 Earnings Release and Conference Call for May 1, 2019 at 4:30 p.m. Eastern Time

  Apr 3, 2019

  SAN DIEGO --(BUSINESS WIRE)--Apr. 3, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2019 financial results after market close on Wednesday, May 1, 2019 . Management will hold a conference call to review the company's first quarter 2019 performance

  Read more
• Summary ToggleDexcom Announces Upcoming Conference Presentation

  Feb 25, 2019

  SAN DIEGO --(BUSINESS WIRE)--Feb. 25, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli , Executive Vice President, Strategy and Corporate Development, will present an update on the

  Read more
• Summary ToggleDexcom G6® CGM System Receives Health Canada Approval

  Feb 22, 2019

  VANCOUVER , Feb. 22, 2019 /CNW/ - Dexcom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), today announced that the company has received Health Canada approval for its next generation Dexcom G6 CGM System for people with diabetes ages two years and up.

  Read more
• Summary ToggleDexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results

  Feb 21, 2019

  The Company also Announces Expansion and Reorganization of its Customer Support Functions SAN DIEGO --(BUSINESS WIRE)--Feb. 21, 2019-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2018 .

  Read more
• Summary ToggleDexcom Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for February 21, 2019 at 4:30 p.m. Eastern Time

  Jan 24, 2019

  SAN DIEGO --(BUSINESS WIRE)--Jan. 24, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2018 financial results after market close on Thursday, February 21, 2019 . Management will hold a conference call to review the company's fourth quarter

  Read more
• Summary ToggleDexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2018 and Provides Initial 2019 Outlook

  Jan 7, 2019

  SAN DIEGO --(BUSINESS WIRE)--Jan. 7, 2019-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2018 to exceed $331 million , an increase of at least 50% over the

  Read more